Director, Transcatheter Heart Valve Interventions at Vanderbilt
@VUMC_heart
.
@mayocliniccv
trained; Opinions are my own and not the views of my employer
Excited to announce that I have been appointed as the Director of Transcatheter Heart Valve Interventions, Vanderbilt University Medical Center.
Thanks to
@colinbarkerMD
,
@ChetRihal
#Brian
Lindman
@JaneFreedmanMD
for the support and opportunities
Our team at Vanderbilt performed the World's first case of InnoValve TMVR larger valve size! Incredibly proud of our amazing Valve, Research, Cath lab, Imaging and Anesthesia teams! Thanks to
@ChetRihal
and InnoValve
@colinbarkerMD
The COAPT Post Approval Study is out in
@JACCJournals
today!
Real world data on 5000 SMR patients treated with MitraClip at 406 sites showed that it was safe and effective.
Free download available at this link for next 50 days:
Interested in the outcomes of TAVR in cardiogenic shock with contemporary balloon-expandable valves?
Our updated TVT registry analysis was just published in European Heart Journal today. My 1st first author publication in EHJ!!
@Dhoble7
@ehj_ed
Great cases of Shockwave IVL
@VUMC_heart
this week. This is a game changer for calcified lesions. Ostial RCA lesion - 3.0 NC wouldnโt expand at 24 atm. After 60 pulses of IVL, full expansion and then stent. No need to change the wire or guide.
@colinbarkerMD
@ShockwaveIVL
Proud to announce that the Vanderbilt Structural and Valve Center has successfully performed the worldโs first Laplace TTVR with in-situ RV lead for symptomatic severe tricuspid regurgitation as part of the EFS. ๐
Outstanding result with no residual TR! This marks a significant
Structural Heart Disease Fellowship โ 2025
Vanderbilt University Medical Center has one opening for the Structural Heart Disease Fellowship. This position offers advanced training in one of the nationโs top Valve Centers.
๐น Apply Here:
The application
Interesting TEER case for functional MR
XTW deployed at A2-P2 with residual moderate MR and mean gradient of 8 mmHg (from severe MR and gradient of 3). What next?
1. Leave it and re-assess in 1 month
2. Place another Clip? If so, which one?
First 3 BASILICA procedures done successfully at Vanderbilt
@VUMC_heart
All patients have done great. First center in TN. Really impressed with the results and innovation by
@AdamGreenbaumMD
, Danny Dvir, Toby Rogers and colleagues at NIH. Opens up a new avenue for high-risk pts
Hot off the press! Our latest study in
@Circulation
reports 1-year outcomes for transseptal Mitral Valve-in-Valve, featuring the largest dataset to date!
With the recent approval for intermediate risk, discover the impressive results of transseptal mitral VIV in patients with
Had a wonderful time
@ACCinTouch
Heart House for the ACC Emerging Faculty Course with exceptional educators
@KBerlacher
@GBarnesMD
@jlinderbaum
@virani_md
and amazing colleagues (could only tag 10)
Thank you ACC for the hospitality and investing in the next generation!
Mixed feelings handing over my desk to incoming structural fellows! Thank you โฆ
@MayoClinicCV
โฉ for incredible 5 years! Looking forward to the next step - joining โฆVanderbilt University โฆ
@VUMChealth
โฉ as an interventional/structural cardiologist
The best feeling one can get -- Receiving the "MVP" award and chain from outgoing IC and SHD fellows. Honored to be a part of their path!
@DrKdotPdot
@vumccardsfit
Had an amazing time teaching the MitraClip 101 course in Austin last week!
Grateful for the opportunity to share and grow with >50 participants from all over the country. Thanks to all who joined and are now ready to start Clipping !
#MitraClip101
@AbbottNews
Excited to officially start commercial TriClip at Vanderbilt today, just as we head to
#NYValves2024
!! Great result with trace residual TR
Privileged to work with such a great structural and imaging team!
@colinbarkerMD
@DrKdotPdot
@amyalford22
It was a great experience attending
#TVT2023
If you are involved in management of valvular/structural heart disease, this is a must attend meeting. Thank you to
@crfheart
for the opportunity to present a late-breaker. Look forward to next year!
LVEF <60% and peak aortic velocity >5 m/s are independent predicting factors of all-cause mortality and cardiovascular mortality in asymptomatic aortic stenosis.
After ranking among the top 10 enrollers in the TRISCEND II trial, weโre thrilled to kick off the commercial TTVR program with Evoque at Vanderbilt.
Huge thanks to our incredible team and VUMC for making it possible! ๐
#TTVR
#Innovation
#VUMC
@colinbarkerMD
@vumcvalve
Another proud moment for the Vanderbilt Structural/Valve Center and Cath Lab!
We recently performed our first Trisol Tricuspid Valve Replacement case as part of the US Early Feasibility Study!!
Very intuitive deployment with no residual TR!
@colinbarkerMD
@vumcvalve
Recording a live case!! A different kind of experience. Case went really well. Our amazing Vanderbilt/VUMC cath lab team pulled it off against all the odds and with a short time for prep!! Proud to work
@VUMChealth
@VUMC_heart
Our team is ready for live cases
@colinbarkerMD
Happy Cath lab, Anesthesia, Research and valve teams after 2 more successful cases of TTVR with Trisol Tricuspid Valve in the EFS!
Participating and enrolling in EFS takes a lot of time and effort, but our team does it with ease. I feel so proud to work alongside all of them!
Great day of structural cases
@vumcvalve
@VUMChealth
with
@colinbarkerMD
Starting with a Watchman โ> Tricuspid Clip โ> double valve (TAVR with Evolut followed by Valve in MAC with Sapien)
Our paper on outcomes of TAVR in Cardiogenic Shock was selected as one of the top 10 papers of 2023 in valvular heart disease across all the major Cardiology and Medicine journals!
Congratulations to all the authors
@Dhoble7
@colinbarkerMD
Had an amazing time at
#NYValves2024
in NYC!! Lots of education, learning, connections and networking! This is the best meeting for Structural Heart Disease enthusiasts. Looking forward to
#NYValves2025
In light of upcoming TCT, here is a tough BASILICA case. Trifecta prosthetic valve stenosis - VTC RCA 2.2 mm and coronary is below the valve tip. Recommended crossing angle - LAO 104 Cr 50. Modified it to LAO 56 Cr 24.
Visualization difficult to cross - used multiple injections
Had an amazing time at
@cvinnovations
#CVI2024
. This is the best case-based structural conference led by
@psorajja
. Learned so many new techniques!!
Our star IC and SHD fellows also presented complex cases in the structural case competitions as semifinalists
Does TEER work in HCM patients who have undergone septal myectomy? Our case series led by
@BassimElSabawi
explores the role of TEER to treat MR after septal myectomy. Role of mitral TEER as a hybrid strategy in high-risk patients?
@vumccardsfit
Had an interesting with MitraClip today. A3 prolapse - severe MR. Placed NTR. Reduction to trace/mild MR. Checked all the stuff. While removing the lockline, the clip opened to 60 degree (by itself) โ> locked it back
@adnanalkhouli
@ReddyTheRobot
@PSorajja
@akcmahi
@SachinGoelMD
It was an honor to present the latest update on the Early Feasibility Study of Innovalve TMVR at NY Valves, on behalf of all the investigators, patients and research teams.
Looking forward to the next steps with this innovative technology
Improvement in gait speed at 1 year after TAVR was associated with reduced mortality/HF, where as baseline gait speed was not - an analysis from REPRISE
@vumcvalve
@VUMC_heart
@JAHA_AHA
@MReardon19
Very excited to be invited as a faculty and being part of the Young Leaders
@CRT_meeting
#CRT2019
My first session as a moderator is on interesting transcatheter mitral cases at 2.30 pm. Thank you to
@rajivxgulati
for nominating me and
@ron_waksman
for the opportunity!
@VUMC_heart
Proud to be part of an exciting session on MR and HF
@HFSA
. Thank you
@LindenfeldJoann
for inviting me to talk about my favorite topic. Heart failure teams are now part of the structural/valve team
Amazing Structural Live cases at
#SCAI2024
Raj Makkar deploying an Evoque in 20 minutes followed by Jamie McCabe doing a SESAME (made it look so easy) in a Fabry patient
@jamiemccabeMD
@scaielm
@SCAI
First Intravenous Lithotripsy case
@VUMC_heart
with
@colinbarkerMD
5 mm vessel with circumferential Ca at border of external/common iliac. Initial pulses at 2 atm โ> unable to pass 16F Esheath (unfortunately didnโt save the flouro)
What did we learn from COAPT and MITRA-FR? This is a great article by our own
@kashishgoelmd
@colinbarkerMD
and
@LindenfeldJoann
providing a contemporary approach to the management of secondary MR
Contemporary Management of Secondary Mitral Regurgitation
Had an amazing time at
#SCAI2022
in Atlanta. Met old friends and made a lot of new ones! Amazing opportunity for networking in interventional cardiology. Highly recommend for all fellows and early career ICs. Look forward to SCAI 2023!
@SCAI
@MyJSCAI
I usually donโt post patient cards..but felt like posting this to share the happiness with my colleagues and teams fighting COVID here in the US and around the world. Recharged me after 2 weeks of busy CCU service
How would you treat this complex mitral case?
- Short posterior leaflet
- Double flail - A3/P3
- Severe MR and pulm edema
Will discuss this case tomorrow at CVI 2024 during the session on โUltimate Mitral Casesโ
@psorajja
@HamidNadira
@SachinGoelMD
@aelsab
Looking forward to presenting an update on Innovalve TMVR technology and EFS at NY Valves next week.
Please join us at the lunch symposium on June 5 and the Innovation session on June 7
#NYValves2024
As we resume services that had been delayed or paused, our primary concern is safety โ protecting our patients, families & staff. Weโve implemented a host of new safety practices to help our patients get the care they need:
We had a challending imaging case of secondary MR recently.
Even with multiple manipulations and different positions of the TEE probe, we could not visualize the posterior leaflet (as seen in the video). This was due to posterior MAC shadowing the leaflet completely.
Newer versions of LAMPOON - All antegrade laceration, ELASTIC (tearing of the Alfieri stitch) and ELASTIC-Clip (tearing of the anterior leaflet and deploying TMVR). Amazing innovations from NIH
Thank you
@akates1
and
@ACCinTouch
for the opportunity to present, to so many junior faculty, early career and FITs. You have set an example! I had a great time meeting so many friends, colleagues and collaborators, and look forward to ACC2020
@a_l_bailey
@TNChapterACC
FDA approval doesnโt say anything about surgical risk assessment in secondary MR. As โฆ
@GreggWStone
โฉ pointed out, it is not required. Will secondary MR patients still need surgical turndown? โฆ
@ReddyTheRobot
โฉ โฆ
@PradeepYadavMD
โฉ โฆ
In-hospital mortality, major bleeding, & vascular complications have all changed over time among nonagenarians undergoing PCI, according to new data, lending support to the view that frailtyโnot ageโshould take precedence
Tricuspid regurgitation is everywhere nowadays! Lots of new devices coming. TEER works great in appropriately selected cases. In this case, TR was just posterior to the pacemaker lead and was abolished with 2 Clips in less than an hour. Great imaging by Ryan LeFevre
@vumcvalve
This is an amazing study. Included very severe asymptomatic AS and had positive results even with 145 pts. EARLY TAVR is much larger and will inform practice
We released it. LA pressure came down
Post release mean gradient was 5 mmHg!! Next day TTW was also 5 mmHg with mild MR.
Most likely, the high gradient was due to valve being pulled up and relaxing it after release helped!
Good learning case for functional MR!
Proud of my wife
@nidhiguptatweet
who just did a BMJ podcast on an important and contemporary wellbeing topic for everyone
@simonsinek
More info:
PS: Tweet is from the browser, not the app (know more once u listen to it!)
Itโs amazing what can be done with transcatheter therapies -
- Mitral VIV in a prohibitive risk surgical pt (
- Perc Ax in a extreme risk, with anomalous Circumflex โ> Evolut Pro (Sapien was considered high-risk of obstructing the Circ)
Discharged home now
@vumcvalve
@VUMC_heart
If you are hooked to your devices and canโt figure out how to achieve life/work-technology balance, consider attending this workshop by
@nidhiguptatweet
It may change your life!
@ACCinTouch
@SCAI
@KHERA_MD
@DrAnkitKPatel
Remember a live case at CRT few yrs ago. A very experienced operator said - never used US in 25 years for radial access. After 15 min of trying, used US and got in